How far are we from the clinical use of placental-derived mesenchymal stem cells?

Bibliography

• Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970;3:393-403
   PubMedGoogle Scholar
• Parolini O, Alviano F, Bagnara GP, et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells. Stem Cells 2008;26:300-11
   PubMed Web of Science ®Google Scholar
• Corrao S, La Rocca G, Lo Iacono M, et al. Umbilical cord revisited: from Wharton’s jelly myofibroblasts to mesenchymal stem cells. Histol Histopathol 2013;28:1235-44
   PubMed Web of Science ®Google Scholar
• Parolini O, Soncini M, Evangelista M, et al. Amniotic membrane and amniotic fluid-derived cells: potential tools for regenerative medicine? Regen Med 2009;4:275-91
   PubMed Web of Science ®Google Scholar
• Fierabracci A, Del Fattore A, Luciano R, Muraca M. Recent advances in mesenchymal stem cell immunomodulation. The role of microvesicles. Cell Transplant 2015;24. 10.3727/096368913X675728
   PubMed Web of Science ®Google Scholar
• Uccelli A, Moretta L, Pistoia V. Immunoregulatory function of mesenchymal stem cells. Eur J Immunol 2006;36:2566-73
   PubMed Web of Science ®Google Scholar
• Kmiecik G, Spoldi V, Silini A, Parolini O. Current view on osteogenic differentiation potential of mesenchymal stromal cells derived from placental tissues. Stem Cell Rev 2014. 10.1007/s12015-014-9569-1
   Web of Science ®Google Scholar
• Rossi D, Pianta S, Magatti M, et al. Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activity. PLoS One 2012;7:e46956
   PubMed Web of Science ®Google Scholar
• Zhu Y, Song X, Wang J, et al. Placental mesenchymal stem cells of fetal origin deposit epigenetic alterations during long-term culture under serum-free condition. Expert Opin Biol Ther 2014;1-18
   Google Scholar
• Parolini O, De D, Rodrigues MF, et al. Placental stem/progenitor cells: isolation and characterization, In: Atala A, Murphy SV, editors. Perinatal stem cells. Springer Science, New York; 2014. p. 373
   Google Scholar
• Parolini O, Soncini M. Placenta as a source of stem cells and as a key organ for fetomaternal tolerance. In: Bhattacharya N, Stubblefield P, editors Regenerative medicine using pregnancy-specific biological substances. Springer-Verlag, London; 2011: p. 460
   Google Scholar
• Magatti M, De Munari S, Vertua E, et al. Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells 2008;26:182-92
   PubMed Web of Science ®Google Scholar
• Parolini O, Souza-Moreira L, O’Valle F, et al. Therapeutic effect of human amniotic membrane-derived cells on experimental arthritis and other inflammatory disorders. Arthritis Rheumatol 2014;66:327-39
   PubMed Web of Science ®Google Scholar
• Magatti M, De Munari S, Vertua E, et al. Amniotic mesenchymal tissue cells inhibit dendritic cell differentiation of peripheral blood and amnion resident monocytes. Cell Transplant 2009;18:899-914
   PubMed Web of Science ®Google Scholar
• Cargnoni A, Piccinelli EC, Ressel L, et al. Conditioned medium from amniotic membrane-derived cells prevents lung fibrosis and preserves blood gas exchanges in bleomycin-injured mice-specificity of the effects and insights into possible mechanisms. Cytotherapy 2014;16:17-32
   PubMed Web of Science ®Google Scholar
• Groh ME, Maitra B, Szekely E, et al. Human mesenchymal stem cells require monocyte-mediated activation to suppress alloreactive T cells. Exp Hematol 2005;33:928-34
   PubMed Web of Science ®Google Scholar
• Silini A, Parolini O, Huppertz B, Lang I. Soluble factors of amnion-derived cells in treatment of inflammatory and fibrotic pathologies. Curr Stem Cell Res Ther 2013;8:6-14
   PubMed Web of Science ®Google Scholar
• Pozzobon M, Piccoli M, De Coppi P. Stem cells from fetal membranes and amniotic fluid: markers for cell isolation and therapy. Cell Tissue Bank 2014;15:199-211
   PubMed Web of Science ®Google Scholar
• Wegmeyer H, Broske AM, Leddin M, et al. Mesenchymal stromal cell characteristics vary depending on their origin. Stem Cells Dev 2013;22:2606-18
   PubMed Web of Science ®Google Scholar
• Soncini M, Vertua E, Gibelli L, et al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 2007;1:296-305
   PubMed Web of Science ®Google Scholar
• Heazlewood CF, Vertua E, Gibelli L, et al. High incidence of contaminating maternal cell overgrowth in human placental mesenchymal stem/stromal cell cultures: a systematic review. Stem Cells Transl Med 2014;3:1305-11
   PubMed Web of Science ®Google Scholar
• Mayer L, Pandak WM, Melmed GY, et al. Safety and tolerability of human placenta-derived cells (PDA001) in treatment-resistant Crohn’s disease: a Phase I study. Inflamm Bowel Dis 2013;19:754-60
   PubMed Web of Science ®Google Scholar
• Chambers DC, Enever D, Ilic N, et al. A phase 1b study of placenta-derived mesenchymal stromal cells in patients with idiopathic pulmonary fibrosis. Respirology 2014;19:1013-18
   PubMed Web of Science ®Google Scholar
• Schellenberg A, Lin Q, Schüler H, et al. Replicative senescence of mesenchymal stem cells causes DNA-methylation changes which correlate with repressive histone marks. Aging 2011;3:873-88
   PubMedGoogle Scholar
• Park S, Kim E, Koh SE, et al. Dopaminergic differentiation of neural progenitors derived from placental mesenchymal stem cells in the brains of Parkinson’s disease model rats and alleviation of asymmetric rotational behavior. Brain Res 2012;1466:158-66
   PubMed Web of Science ®Google Scholar
• Yun HM, Kim HS, Park KR, et al. Placenta-derived mesenchymal stem cells improve memory dysfunction in an Abeta1-42-infused mouse model of Alzheimer’s disease. Cell Death Dis 2013;4:e958
   PubMed Web of Science ®Google Scholar
• Kim KS, Kim HS, Park JM, et al. Long-term immunomodulatory effect of amniotic stem cells in an Alzheimer’s disease model. Neurobiol Aging 2013;34:2408-20
   PubMed Web of Science ®Google Scholar
• Fisher-Shoval Y, Barhum Y, Sadan O, et al. Transplantation of placenta-derived mesenchymal stem cells in the EAE mouse model of MS. J Mol Neurosci 2012;48:176-84
   PubMed Web of Science ®Google Scholar
• Cargnoni A, Gibelli L, Tosini A, et al. Transplantation of allogeneic and xenogeneic placenta-derived cells reduces bleomycin-induced lung fibrosis. Cell Transplant 2009;18:405-22
   PubMed Web of Science ®Google Scholar
• Cargnoni A, Ressel L, Rossi D, et al. Conditioned medium from amniotic mesenchymal tissue cells reduces progression of bleomycin-induced lung fibrosis. Cytotherapy 2012;14:153-61
   PubMed Web of Science ®Google Scholar
• Ventura C, Cantoni S, Bianchi F, et al. Hyaluronan mixed esters of butyric and retinoic Acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts. J Biol Chem 2007;282:14243-52
   PubMed Web of Science ®Google Scholar
• Tsuji H, Miyoshi S, Ikegami Y, et al. Xenografted human amniotic membrane-derived mesenchymal stem cells are immunologically tolerated and transdifferentiated into cardiomyocytes. Circ Res 2010;106:1613-23
   PubMed Web of Science ®Google Scholar
• Vaghjiani V, Vaithilingam V, Tuch B, et al. Deriving hepatocyte-like cells from placental cells for transplantation. Curr Stem Cell Res Ther 2013;8:15-24
   PubMedGoogle Scholar